Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06618 JD HEALTH
RTNominal down72.000 -2.100 (-2.834%)
Research Report

16/07/2021 17:22

{I-bank focus}HSBC lowers JD Health (06618) to HK$149

[ET Net News Agency, 16 July 2021] HSBC Global Research lowered its target price for JD
Health (06618) to HK$149 from HK$154 and maintained its "buy" rating.
The research house said it lifts its top line estimate for FY21e by 4%, but lower its
FY21e/22e/23e net profit estimates by 37%/27%/33% respectively, after factoring in the
company's investment plans in the next three years. (RC)

Remark: Real time quote last updated: 27/10/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.